These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 8567030)
1. Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells. Zeng L; An S; Goetzl EJ Immunology; 1995 Dec; 86(4):620-8. PubMed ID: 8567030 [TBL] [Abstract][Full Text] [Related]
2. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor. Zeng L; An S; Goetzl EJ J Biol Chem; 1996 Nov; 271(44):27744-50. PubMed ID: 8910368 [TBL] [Abstract][Full Text] [Related]
3. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Zeng L; An S; Goetzl EJ Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase C activation reduces microglial cyclic AMP response to prostaglandin E2 by interfering with EP2 receptors. Patrizio M; Colucci M; Levi G J Neurochem; 2000 Jan; 74(1):400-5. PubMed ID: 10617145 [TBL] [Abstract][Full Text] [Related]
5. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells. Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts. Noguchi K; Iwasaki K; Shitashige M; Ishikawa I J Periodontal Res; 1999 Nov; 34(8):478-85. PubMed ID: 10697805 [TBL] [Abstract][Full Text] [Related]
7. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts. Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK; Barnes PJ; Giembycz MA Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts. Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045 [TBL] [Abstract][Full Text] [Related]
10. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells. Zeng L; An S; Goetzl EJ J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406 [TBL] [Abstract][Full Text] [Related]
11. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts. Choung J; Taylor L; Thomas K; Zhou X; Kagan H; Yang X; Polgar P J Cell Biochem; 1998 Nov; 71(2):254-63. PubMed ID: 9779823 [TBL] [Abstract][Full Text] [Related]
12. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627 [TBL] [Abstract][Full Text] [Related]
13. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development. Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476 [TBL] [Abstract][Full Text] [Related]
14. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Regan JW; Bailey TJ; Pepperl DJ; Pierce KL; Bogardus AM; Donello JE; Fairbairn CE; Kedzie KM; Woodward DF; Gil DW Mol Pharmacol; 1994 Aug; 46(2):213-20. PubMed ID: 8078484 [TBL] [Abstract][Full Text] [Related]